Consistently, based on TCGA transcriptome data, we found that the expression of SF3A3 in CRC patients was significantly higher in tumor tissues than that in adjacent normal tissues (P < 0.05, Fig. 3A). The gene discussed is SF3A3; the disease is neoplasm.